About LabCentral
LabCentral is a company based in Cambridge (United States) founded in 2012.. LabCentral has raised $13 million across 2 funding rounds from investors including Astellas Pharma and Massachusetts Life Sciences Center. The company has 91 employees as of December 31, 2023. LabCentral offers products and services including Lab Spaces, Golden Tickets, and Startup Programs. LabCentral operates in a competitive market with competitors including SmartLabs, NSG BioLabs, Livance, LabShares and BioLabs, among others.
- Headquarter Cambridge, United States
- Employees 91 as on 31 Dec, 2023
-
Sectors
Real Estate & ConstructionHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Labcentral Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13 M (USD)
in 2 rounds
-
Latest Funding Round
$13 M (USD), Series B
Oct 01, 2019
-
Investors
Astellas Pharma
& 1 more
-
Employee Count
91
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LabCentral
LabCentral offers a comprehensive portfolio of products and services, including Lab Spaces, Golden Tickets, and Startup Programs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides equipped labs for biotech research and development
Offers funding opportunities for startup founders in biotech
Delivers resources and training for early-stage innovators
Unlock access to complete
Funding Insights of LabCentral
LabCentral has successfully raised a total of $13M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $13 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $13.0M
-
First Round
First Round
(01 Oct 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2019 | Amount | Grant - LabCentral | Valuation |
investors |
|
| Oct, 2019 | Amount | Series B - LabCentral | Valuation | Astellas Pharma |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in LabCentral
LabCentral has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Astellas Pharma and Massachusetts Life Sciences Center. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life sciences innovation is supported through funding and programs.
|
Founded Year | Domain | Location | |
|
Generic pharmaceuticals are developed, manufactured, and marketed worldwide.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by LabCentral
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - LabCentral
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Labcentral Comparisons
Competitors of LabCentral
LabCentral operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SmartLabs, NSG BioLabs, Livance, LabShares and BioLabs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Coworking lab spaces for research teams are provided by SmartLabs.
|
|
| domain | founded_year | HQ Location |
Level 2 biosafety co-working labs and office spaces are provided.
|
|
| domain | founded_year | HQ Location |
Managed medical co-working spaces are provided on a pay-as-you-go basis.
|
|
| domain | founded_year | HQ Location |
Provider of shared and private laboratory spaces with equipment and services.
|
|
| domain | founded_year | HQ Location |
Provides co-working lab and office spaces for biotech startups.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Labcentral
Frequently Asked Questions about LabCentral
When was LabCentral founded?
LabCentral was founded in 2012 and raised its 1st funding round 7 years after it was founded.
Where is LabCentral located?
LabCentral is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of LabCentral?
Maggie Otoole is the current CEO of LabCentral.
Is LabCentral a funded company?
LabCentral is a funded company, having raised a total of $13M across 2 funding rounds to date. The company's 1st funding round was a Grant of $5M, raised on Oct 01, 2019.
How many employees does LabCentral have?
As of Dec 31, 2023, the latest employee count at LabCentral is 91.
What does LabCentral do?
LabCentral was established in 2012 as a non-profit entity in Cambridge, United States, focused on the biotech sector. Permitted laboratory and office spaces are supplied to early-stage startups comprising scientists and entrepreneurs. Administrative support, skilled laboratory staff, a series of expert speakers in relevant domains, and essential services for launching lab operations are made available to residents.
Who are the top competitors of LabCentral?
LabCentral's top competitors include SmartLabs, NSG BioLabs and Livance.
What products or services does LabCentral offer?
LabCentral offers Lab Spaces, Golden Tickets, and Startup Programs.
Who are LabCentral's investors?
LabCentral has 2 investors. Key investors include Astellas Pharma, and Massachusetts Life Sciences Center.